New treatments found for tough blood cancers
Researchers from King's have identified a new way to treat certain blood cancers using existing drugs, by turning a once-dismissed part of our DNA into a therapeutic target.
Sep 11, 2025
0
17
Immune System Diseases: News and Research on Leukemia, Lymphoid
MeSH tree: C20.683.515.528
'Cell-in-cell' mechanism explains how blood cancer uses bone marrow to evade treatment
In a recently published study, researchers at Fox Chase Cancer Center revealed for the first time that cancer cells can evade anti-cancer drugs by entering and surviving within bone marrow fibroblasts, a phenomenon they describe ...
Aug 12, 2025
0
18
Finding a clue to the origin of treatment-resistant leukemia in kids
New fundamental research could help combat treatment-resistant leukemia and prevent relapses in children and adolescents. A group of scientists studied a certain type of leukemia and identified individual stem cell-like cells ...
Aug 5, 2025
0
50
Immunoglobulin replacement therapy shows no reduction in serious infections for chronic lymphocytic leukemia
In patients with chronic lymphocytic leukemia (CLL), regular treatment with immunoglobulin replacement therapy was not associated with a reduced risk of serious infections requiring hospitalization, according to a study published ...
Jul 31, 2025
0
14
Exercise could ease symptoms for people with chronic lymphocytic leukemia, support and guidance are lacking: Study
Personalized exercise guidance is needed for people living with chronic lymphocytic leukemia (CLL), the most common type of blood cancer, according to a new study led by the University of Surrey.
Jul 16, 2025
0
15
CAR-T cells engineered to attack two leukemia proteins show promise in preclinical tests
T-cell acute lymphoblastic leukemia (T-ALL) is a highly aggressive form of blood cancer that can occur in both children and adults. It is characterized by failures in the maturation of T-lymphocytes, key immune cells involved ...
Jul 7, 2025
0
34
Researcher publishes three studies advancing treatment for rare and aggressive lymphoma
Three major Mount Sinai research studies offer new hope for patients facing chronic lymphocytic leukemia (CLL), a rare type of blood cancer. The studies were led by Adam Kittai, MD, Associate Professor of Medicine (Hematology ...
Jun 30, 2025
0
20
Researchers find that genetic ancestry influences how gene mutations impact cancer prognosis
Investigators have unveiled for the first time that changes in certain genes affect an aggressive cancer, T-cell acute lymphoblastic leukemia (T-ALL), differently depending on genetic ancestry.
Jun 24, 2025
0
15
Kinder, smarter leukemia treatment is transforming lives
Personalized drug treatments have outperformed chemotherapy for leukemia patients in a trial led by Leeds researchers. Newly published, long-term results of the UK-wide FLAIR trial could transform treatment for chronic lymphocytic ...
Jun 17, 2025
0
25
Innovative immunotherapy shows promise against aggressive T cell cancers
A new type of immunotherapy that targets aggressive blood cancers shows promising results alongside manageable side effects, according to the results of an international Phase I/II clinical trial led by researchers at Washington ...
May 30, 2025
0
53
